November 08, 2019 - PHARMACEUTIQUES
"Italian Success Story" of the magazine PHARMACEUTIQUES, n ° 270, Oct 2019
Download PDF
August 01, 2019 - ITALFARMACO
Italfarmaco Enters Binding Term Sheet Agreement with Neupharma for an Exclusive Option to Develop and Commercialize Inhaled Teicoplanin
Download PDF
April 02, 2019 - Il giorno Milano
Biosimilar drugs, new frontier
Download PDF
February 28, 2019 - ITFPHARMA
ITF Pharma has been named an honoree for the 2018 Patient Impact Award, presented by Life Sciences Pennsylvania, for the successful launch and approval of TIGLUTIK
Download PDF
November 30, 2018 - Adnkronos
The project: make the first move take care of your bones. The "awareness" initiative on osteoporosis is supported by Abiogen and Italfarmaco and will interest 11 scientific societies involved in the study of metabolic bone diseases.
Link to the article
September 06, 2018 - ITFPHARMA
ITF PHARMA announces FDA approval of TIGLUTIK™ (riluzole) oral suspension for the tratment of amyotrophic lateral sclerosis (ALS)
Download PDF
September 06, 2018 - ABOUTPHARMA ONLINE
Sla, Fda approva riluzolo di Italfarmaco
Download PDF (Only in italian)
June 28, 2017 - Il Giorno Milano
Malattia rara. Un accordo da 5,6 milioni per la ricerca
Download PDF
March 27, 2017 - Il Sole24 Ore
Più calcio e vitamina D per ridurre le fratture da osteoporosi e far risparmiare il Ssn
Link to the article
March 25, 2015 - Pharmakronos
L'accordo Chemi-Teva dà i suoi frutti
Link to the article